drugset / Trial / NCT02093273
Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)
RandomizedParallel-groupDouble-blindPrevention
Summary
The objective of this study is to compare the antibody response 30 days after two doses of t OPV
Timeline
- Start
- 2013-05
- Primary completion
- 2014-01
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tOPV | Vaccine | 0.1 ml | Oral |
Indications
No indication recorded.